TY - JOUR
T1 - Epidemiology of hospitalizations associated with invasive candidiasis, United States, 2002-2012
AU - Strollo, Sara
AU - Lionakis, Michail S.
AU - Adjemian, Jennifer
AU - Steiner, Claudia A.
AU - Prevots, D. Rebecca
N1 - Funding Information:
This study was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health(NIH).
Publisher Copyright:
© 2017, Centers for Disease Control and Prevention (CDC). All rights reserved.
PY - 2017/1
Y1 - 2017/1
N2 - Invasive candidiasis is a major nosocomial fungal disease in the United States associated with high rates of illness and death. We analyzed inpatient hospitalization records from the Healthcare Cost and Utilization Project to estimate incidence of invasive candidiasis-associated hospitalizations in the United States. We extracted data for 33 states for 2002-2012 by using codes from the International Classification of Diseases, 9th Revision, Clinical Modification, for invasive candidiasis; we excluded neonatal cases. The overall age-adjusted average annual rate was 5.3 hospitalizations/100,000 population. Highest risk was for adults ≥65 years of age, particularly men. Median length of hospitalization was 21 days; 22% of patients died during hospitalization. Median unadjusted associated cost for inpatient care was $46,684. Age-adjusted annual rates decreased during 2005-2012 for men (annual change-3.9%) and women (annual change-4.5%) and across nearly all age groups. We report a high mortality rate and decreasing incidence of hospitalizations for this disease.
AB - Invasive candidiasis is a major nosocomial fungal disease in the United States associated with high rates of illness and death. We analyzed inpatient hospitalization records from the Healthcare Cost and Utilization Project to estimate incidence of invasive candidiasis-associated hospitalizations in the United States. We extracted data for 33 states for 2002-2012 by using codes from the International Classification of Diseases, 9th Revision, Clinical Modification, for invasive candidiasis; we excluded neonatal cases. The overall age-adjusted average annual rate was 5.3 hospitalizations/100,000 population. Highest risk was for adults ≥65 years of age, particularly men. Median length of hospitalization was 21 days; 22% of patients died during hospitalization. Median unadjusted associated cost for inpatient care was $46,684. Age-adjusted annual rates decreased during 2005-2012 for men (annual change-3.9%) and women (annual change-4.5%) and across nearly all age groups. We report a high mortality rate and decreasing incidence of hospitalizations for this disease.
UR - http://www.scopus.com/inward/record.url?scp=85006371390&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85006371390&partnerID=8YFLogxK
U2 - 10.3201/eid2301.161198
DO - 10.3201/eid2301.161198
M3 - Article
C2 - 27983497
AN - SCOPUS:85006371390
SN - 1080-6040
VL - 23
SP - 7
EP - 13
JO - Emerging infectious diseases
JF - Emerging infectious diseases
IS - 1
ER -